Aguirre Castaneda Roxana L, Kumar Seema, Voigt Robert G, Leibson Cynthia L, Barbaresi William J, Weaver Amy L, Killian Jill M, Katusic Slavica K
Division of Pediatric Endocrinology and Metabolism, University of Illinois College of Medicine at Peoria, Peoria.
Division of Pediatric Endocrinology and Metabolism, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN.
Mayo Clin Proc. 2016 Mar;91(3):352-61. doi: 10.1016/j.mayocp.2015.09.017. Epub 2016 Feb 4.
To assess obesity rates during childhood and young adulthood in patients with attention-deficit/hyperactivity disorder (ADHD) and age- and sex-matched controls derived from a population-based birth cohort because cross-sectional studies suggest an association between ADHD and obesity.
Study subjects included patients with childhood ADHD (n=336) and age- and sex-matched non-ADHD controls (n=665) from a 1976 to 1982 birth cohort (N=5718). Height, weight, and stimulant treatment measurements were abstracted retrospectively from medical records documenting care provided from January 1, 1976, through August 31, 2010. The association between ADHD and obesity in patients with ADHD relative to controls was estimated using Cox models.
Patients with attention-deficit/hyperactivity disorder were 1.23 (95% CI, 1.00-1.50; P<.05) times more likely to be obese during the follow-up period than were non-ADHD controls. This association was not statistically significant in either sex (female participants: hazard ratio [HR], 1.49; 95% CI, 0.98-2.27; P=.06; male participants HR, 1.17, 95% CI, 0.92-1.48; P=.20). Patients with ADHD who were not obese as of the date ADHD research diagnostic criteria were met were 1.56 (95% CI, 1.14-2.13; P<.01) times more likely to be obese during the subsequent follow-up than were controls. This association was statistically significant in female study subjects (HR, 2.02; 95% CI, 1.13-3.60; P=.02), but not in male participants (HR, 1.41; 95% CI, 0.97-2.05; P=.07). A higher proportion of patients with ADHD were obese after the age of 20 years compared with non-ADHD controls (34.4% vs 25.1%; P=.01); this difference was observed only in female patients (41.6% vs 19.2%). There were no differences in obesity rates between stimulant-treated and nontreated patients with ADHD.
Childhood ADHD is associated with obesity during childhood and young adulthood in females. Treatment with stimulant medications is not associated with the development of obesity up to young adulthood.
由于横断面研究提示注意力缺陷多动障碍(ADHD)与肥胖之间存在关联,因此评估基于人群的出生队列中ADHD患者及年龄和性别匹配的对照儿童期和青年期的肥胖率。
研究对象包括1976年至1982年出生队列(N = 5718)中的儿童ADHD患者(n = 336)以及年龄和性别匹配的非ADHD对照(n = 665)。回顾性提取1976年1月1日至2010年8月31日医疗记录中的身高、体重和兴奋剂治疗测量数据。使用Cox模型估计ADHD患者相对于对照中ADHD与肥胖之间的关联。
在随访期间,注意力缺陷多动障碍患者肥胖的可能性是非ADHD对照的1.23倍(95% CI,1.00 - 1.50;P <.05)。这种关联在任何性别中均无统计学意义(女性参与者:风险比[HR],1.49;95% CI,0.98 - 2.27;P =.06;男性参与者HR,1.17,95% CI,0.92 - 1.48;P =.20)。在符合ADHD研究诊断标准时未肥胖的ADHD患者在随后的随访期间肥胖的可能性是对照的1.56倍(95% CI,1.14 - 2.13;P <.01)。这种关联在女性研究对象中有统计学意义(HR,2.02;95% CI,1.13 - 3.60;P =.02),但在男性参与者中无统计学意义(HR,1.41;95% CI,0.97 - 2.05;P =.07)。与非ADHD对照相比,20岁后ADHD患者肥胖的比例更高(34.4% 对25.1%;P =.01);这种差异仅在女性患者中观察到(41.6% 对19.2%)。接受兴奋剂治疗和未接受治疗的ADHD患者之间肥胖率无差异。
儿童期ADHD与女性儿童期和青年期肥胖有关。直至青年期,使用兴奋剂药物治疗与肥胖的发生无关。